View in EDS

Heterogeneous Responses to High-Dose Testosterone in Castration-Resistant Prostate Cancer Tumors with Mixed Rb-Proficient and Rb-Deficient Cells.

Saved in:
Bibliographic Details
Title: Heterogeneous Responses to High-Dose Testosterone in Castration-Resistant Prostate Cancer Tumors with Mixed Rb-Proficient and Rb-Deficient Cells.
Authors: Labaf M; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Department of Mathematics, University of Massachusetts Boston, Boston, Massachusetts.; Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts., Han W; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Department of Biology, University of Massachusetts Boston, Boston, Massachusetts.; Human Biology Division, Fred Hutchinson Cancer Center, Washington., Zhang S; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Department of Biology, University of Massachusetts Boston, Boston, Massachusetts., Liu M; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Department of Biology, University of Massachusetts Boston, Boston, Massachusetts., Patten ND; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Department of Biology, University of Massachusetts Boston, Boston, Massachusetts., Li M; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Department of Biology, University of Massachusetts Boston, Boston, Massachusetts.; Division of Urology, Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Patalano S; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Department of Biology, University of Massachusetts Boston, Boston, Massachusetts., Macoska JA; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Department of Biology, University of Massachusetts Boston, Boston, Massachusetts., Balk SP; Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts., Han D; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Department of Biology, University of Massachusetts Boston, Boston, Massachusetts., Zarringhalam K; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts., Cai C; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Department of Biology, University of Massachusetts Boston, Boston, Massachusetts.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2025 May 02; Vol. 24 (5), pp. 772-783.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40116305
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Heterogeneous Responses to High-Dose Testosterone in Castration-Resistant Prostate Cancer Tumors with Mixed Rb-Proficient and Rb-Deficient Cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Labaf+M%22">Labaf M</searchLink>; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Department of Mathematics, University of Massachusetts Boston, Boston, Massachusetts.; Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Han+W%22">Han W</searchLink>; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Department of Biology, University of Massachusetts Boston, Boston, Massachusetts.; Human Biology Division, Fred Hutchinson Cancer Center, Washington.<br /><searchLink fieldCode="AU" term="%22Zhang+S%22">Zhang S</searchLink>; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Department of Biology, University of Massachusetts Boston, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Liu+M%22">Liu M</searchLink>; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Department of Biology, University of Massachusetts Boston, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Patten+ND%22">Patten ND</searchLink>; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Department of Biology, University of Massachusetts Boston, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Li+M%22">Li M</searchLink>; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Department of Biology, University of Massachusetts Boston, Boston, Massachusetts.; Division of Urology, Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Patalano+S%22">Patalano S</searchLink>; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Department of Biology, University of Massachusetts Boston, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Macoska+JA%22">Macoska JA</searchLink>; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Department of Biology, University of Massachusetts Boston, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Balk+SP%22">Balk SP</searchLink>; Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Han+D%22">Han D</searchLink>; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Department of Biology, University of Massachusetts Boston, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Zarringhalam+K%22">Zarringhalam K</searchLink>; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Cai+C%22">Cai C</searchLink>; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts.; Department of Biology, University of Massachusetts Boston, Boston, Massachusetts.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2025 May 02; Vol. 24 (5), pp. 772-783.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40116305
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-24-0716
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 772
    Titles:
      – TitleFull: Heterogeneous Responses to High-Dose Testosterone in Castration-Resistant Prostate Cancer Tumors with Mixed Rb-Proficient and Rb-Deficient Cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Labaf M
      – PersonEntity:
          Name:
            NameFull: Han W
      – PersonEntity:
          Name:
            NameFull: Zhang S
      – PersonEntity:
          Name:
            NameFull: Liu M
      – PersonEntity:
          Name:
            NameFull: Patten ND
      – PersonEntity:
          Name:
            NameFull: Li M
      – PersonEntity:
          Name:
            NameFull: Patalano S
      – PersonEntity:
          Name:
            NameFull: Macoska JA
      – PersonEntity:
          Name:
            NameFull: Balk SP
      – PersonEntity:
          Name:
            NameFull: Han D
      – PersonEntity:
          Name:
            NameFull: Zarringhalam K
      – PersonEntity:
          Name:
            NameFull: Cai C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 05
              Text: 2025 May 02
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1